Rani Therapeutics Holdings, Inc. Annual Interest Expense in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rani Therapeutics Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2024.
  • Rani Therapeutics Holdings, Inc. Interest Expense for the quarter ending December 31, 2024 was $1.13M, a 13.1% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. Interest Expense for the twelve months ending December 31, 2024 was $5.03M, a 1.02% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2024 was $5.03M, a 1.02% decline from 2023.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2023 was $5.09M, a 375% increase from 2022.
  • Rani Therapeutics Holdings, Inc. annual Interest Expense for 2022 was $1.07M, a 130% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.03M -$52K -1.02% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $5.09M +$4.01M +375% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $1.07M +$605K +130% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $466K +$342K +276% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $124K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.